SHARE
COPY LINK

COVID-19

No European deaths directly tied to Covid-19 vaccine, say scientists

Scientists in Europe say evidence available so far does not incriminate the new anti-Covid vaccines in the numerous deaths of elderly and frail people shortly after they had received the coronavirus vaccine.

No European deaths directly tied to Covid-19 vaccine, say scientists
A Pfizer/BioNtech Covid-19 vaccine being prepared. Andy Buchanan / AFP

Health agencies stress however that the vast majority of post-vaccination fatalities were elderly, already vulnerable and often sick.

Here's a review of the situation:

Elderly, vulnerable

Norway sparked alarm last week when it reported the deaths of 33 of some 20,000 retirement home residents who had received a first shot of the Pfizer/BioNTech vaccine.

At least 13 of the fatalities were not only very elderly but also considered frail with serious ailments, the Norwegian Institute of Public Health said.

While it noted that no analysis had yet been carried out on the causes of the deaths, it suggested that with the aged and vulnerable the normal side effects of vaccination such as fever or nausea could have contributed.

Outside Norway the news raised widespread concern and fed anti-vaccine scepticism, prompting the authorities to stress that no link had been established between the vaccine and post-jab deaths.

READ MORE: How has Norway reacted to elderly Covid vaccine deaths?

In France, of 800,000 people vaccinated, nine deaths of chronically ill residents of care and retirement homes were recorded by Friday.

The national medicines agency ANSM said that based on available evidence, “Nothing leads to the conclusion that the reported deaths were linked to vaccination.”

Other examples include 13 deaths of elderly people recorded in Sweden and seven in Iceland, all with no link established.

In Portugal, a care worker died two days after being inoculated but the justice ministry said a post-mortem found no direct link.

France's interior ministry on January 18 listed 71 “observations of death” in Europe of people who had the inoculation, but offered no further details.

Continued monitoring

The European Medicines Agency said that despite the deaths, “to date no specific concerns have been identified with Comirnaty”, the commercial name for the Pfizer shot.

The EMA noted that the authorities investigate fatalities to determine whether the vaccine was responsible.

National and European agencies check any problems with vaccinations reported by health professionals, pharmaceutical firms and patients themselves.

For the moment, the number and type of deaths among those vaccinated are not considered abnormal, with no cause-and-effect relationship identified.

In many countries — such as France, Norway, Britain and Spain — the frail and elderly are first in line for vaccinations.

“It is not unexpected that some of these people may naturally fall ill due to their age or underlying conditions shortly after being vaccinated, without the vaccine playing any role in that,” the UK medicines regulator MHRA said.

Transparency, reassurance 

The deaths are a highly sensitive issue, and approaches to informing the public vary.

France and some Nordic countries have reported post-vaccination deaths and detailed the potential side effects of the jabs even if no link has been established.

But Britain's MHRA said it would make a statement at a later date, possibly seeking to avoid spreading alarm.

“We will publish details of all suspected reactions reported in association with approved Covid-19 vaccines, along with our assessment of the data on a regular basis in the future,” it said.

In any event, European health officials say the deaths do not call into question the safety of the vaccines.

Norway has not changed its vaccination rollout, even if it has recommended doctors consider the overall health of the most frail before giving them the jab, the policy of numerous other countries.

Globally, more than 60 million doses have been received in at least 64 countries or territories, according to an AFP tally on Saturday.

STRIKES

Pharmacists in France to strike at the end of May

Unions representing French pharmacists have called for walkouts at the end of May in protest over drug shortages, wages and the sale of medication on the internet.

Pharmacists in France to strike at the end of May

The primary union, the union for community pharmacists (Union des syndicats de pharmaciens d’officine, or USPO) has called for on-call pharmacists to walk out during the Pentecost long-weekend (May 18th to 20th), and for all pharmacies across France to close on Thursday, May 30th.

On-call pharmacists (pharmacie de garde) are those working on Sundays and bank holidays (like Pentecost), as most other pharmacies close on these dates.

While it is still not clear how many pharmacists will walk out, the call for strikes is nationwide and it may be best to plan to pick up any important medicine ahead of time.

Why the strike?

Drug shortages are a large part of the problem because they reportedly force pharmacists to spend more of their working hours doing drug research to be able to offer alternatives to patients. 

Pierre-Olivier Variot, the head of the union for community pharmacists, told Franceinfo that this has led to an extra 12 hours of research time for the average pharmacy.

“These are 12 hours during which we cannot take care of patients. We’re also dealing with tired patients who are frustrated we do not have their treatment,” he said.

Variot also explained that wages have not kept up with inflation, and as a result some pharmacies have had to close. 

Unions are also calling for the French government to better regulate the sale of medication on the internet, in order to ensure quality and safety standards.

Why the shortage of medicines?

The issue has been longstanding, and the situation was made worse during the Covid-19 pandemic.

The French Medicines Safety Agency (ANSM) reported that, in 2023, it had 4,925 medicines either out of stock or at risk of being out of stock, an increase of 30.9 percent in medicine shortages compared to 2022.

You can find the list of medications in short supply here.

A spokesperson from ANSM told Le Point in February that there are several things causing the problem, with many of them taking place on a global level.

“There are challenges with the manufacture of raw materials and finished products, as well as qualify defects in the drugs, insufficient production capacity, and division within the manufacturing stages,” the ANSM said.

On top of that, many factories dealing with raw materials are located outside of Europe.

SHOW COMMENTS